Show notes at pharmacyjoe.com/episode1045.
In this episode, I’ll discuss possible design flaws in a recent study that suggested cefepime has a mortality benefit over piperacillin-tazobactam.
Critical Care and Hospital Pharmacy Resources for Hospital Pharmacists, PGY-1 Pharmacy Residents, PharmD students, and Preceptors
Show notes at pharmacyjoe.com/episode1045.
In this episode, I’ll discuss possible design flaws in a recent study that suggested cefepime has a mortality benefit over piperacillin-tazobactam.
Leave a Reply